Emergence of entecavir-resistant mutations in nucleos(t)ide-naive Japanese patients infected with hepatitis B virus: Virological breakthrough is also dependent on adherence to medication

References

• Chang MH, You SL, Chen CJ, Liu CJ, Lee CM, Lin SM, Decreased incidence of hepatocellular carcinoma in hepatitis B vaccines: a 20-year follow-up study. J Natl Cancer Inst 2009;101:1348–55.
   PubMed Web of Science ®Google Scholar
• Di Bisceglie AM. Hepatitis B and hepatocellular carcinoma. Hepatology 2009;49(5 Suppl):S56–60.
   PubMedGoogle Scholar
• Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2005;34(Suppl 1):S1–3.
   PubMedGoogle Scholar
• Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007;45:507–39.
   PubMed Web of Science ®Google Scholar
• Wu S, Fukai K, Imazeki F, Arai M, Kanda T, Yonemitsu Y, Yokosuka O. Initial virological response and viral mutation with adefovir dipivoxil added to ongoing lamivudine therapy in lamivudine-resistant chronic hepatitis B. Dig Dis Sci 2011;56:1207–14.
   PubMedGoogle Scholar
• Chen CJ, Yang H, Su J, Jen CL, You SL, Lu SN, Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65–73.
   PubMed Web of Science ®Google Scholar
• Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ, Predicting cirrhosis based on the level of circulating hepatitis B viral load. Gastroenterology 2006;130:678–86.
   PubMed Web of Science ®Google Scholar
• Chotiyaputta W, Peterson C, Ditah FA, Goodwin D, Lok AS. Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B. J Hepatol 2011;54:12–18.
   PubMed Web of Science ®Google Scholar
• Yuen MF, Lai CL. Treatment of chronic hepatitis B: evolution over two decades. J Gastroenterol Hepatol 2011;26(Suppl 1):S138–43.
   PubMedGoogle Scholar
• Yokosuka O, Takaguchi K, Fujioka S, Shindo M, Chayama K, Kobayashi H, Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection. J Hepatol 2010;52:791–9.
   PubMed Web of Science ®Google Scholar
• Kumada H, Okanoue T, Onji M, Moriwaki H, Izumi N, Tanaka E, Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan. Hepatol Res 2010;40:1–7.
   PubMedGoogle Scholar
• Wu S, Kanda T, Imazeki F, Arai M, Yonemitsu Y, Nakamoto S, Hepatitis B virus e antigen downregulates cytokine production in human hepatoma cell lines. Viral Immunol 2010;23:467–76.
   PubMedGoogle Scholar
• Usuda S, Okamoto H, Iwanari H, Baba K, Tsuda F, Miyakawa Y, Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product. J Virol Methods 1999;80:97–112.
   PubMed Web of Science ®Google Scholar
• Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518–26.
   PubMed Web of Science ®Google Scholar
• Ishibashi H, Maruyama H, Takahashi M, Fujiwara K, Imazeki F, Yokosuka O. Assessment of hepatic fibrosis by analysis of the dynamic behavior of microbubbles during contrast ultrasonography. Liver Int 2010;30:1355–63.
   PubMed Web of Science ®Google Scholar
• Kanda T, Jeong SH, Imazeki F, Fujiwara K, Yokosuka O. Analysis of 5′ nontranslated region of hepatitis A viral RNA genotype I from South Korea: comparison with disease severities. PLoS One 2010;5:e15139.
   PubMedGoogle Scholar
• Tenney DJ, Rose RE, Baldick CJ, Pokornowski KA, Eggers BJ, Fang J, Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy. Hepatology 2009;49:1503–14.
   PubMed Web of Science ®Google Scholar
• Seta T, Yokosuka O, Imazeki F, Tagawa M, Saisho H. Emergence of YMDD motif mutants of hepatitis B virus during lamivudine treatment of immunocompetent type B hepatitis patients. J Med Virol 2000;60:8–16.
   PubMed Web of Science ®Google Scholar
• Yim HJ, Hussain M, Liu Y, Wong SN, Fung SK, Lok AS. Evolution of multi-drug resistant hepatitis B virus during sequential therapy. Hepatology 2006;44:703–12.
   PubMed Web of Science ®Google Scholar
• Kobashi H, Fujioka S, Kawaguchi M, Kumada H, Yokosuka O, Hayashi N, Two cases of development of entecavir resistance during entecavir treatment for nucleotide-naïve chronic hepatitis B. Hepatol Int 2009;3:403–10.
   PubMed Web of Science ®Google Scholar
• Mukaide M, Tanaka Y, Shin-I T, Yuen MF, Kurbanov F, Yokosuka O, Mechanism of entecavir resistance of hepatitis B virus with viral breakthrough as determined by long-term clinical assessment and molecular docking simulation. Antimicrob Agents Chemother 2010;54:882–9.
   PubMedGoogle Scholar
• Sumi H, Yokosuka O, Seki N, Arai M, Imazeki F, Kurihara T, Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 2003;37:19–26.
   PubMed Web of Science ®Google Scholar
• Lin CL, Kao JH. The clinical implications of hepatitis B virus genotype: recent advances. J Gastroenterol Hepatol 2011;26(Suppl 1):123–30.
   PubMedGoogle Scholar
• Luire Y, Manns MP, Gish RG, Chang TT, Yurdaydin C, Lai CL, The efficacy of entecavir is similar regardless of disease-related baseline subgroups in treatment of nucleoside-naïve, HBeAg(+) and HBeAg(-) patients with chronic hepatitis B. J Hepatol 2005;42(Suppl 2):184.
   Google Scholar
• Odegard PS, Gray SL. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educ 2008;34:692–7.
   PubMed Web of Science ®Google Scholar
• Hill MN, Miller NH, Degeest S, American Society of Hypertension Writing Group, Materson BJ, Black HR, Adherence and persistence with taking medication to control high blood pressure. J Am Soc Hypertens 2011;5:56–63.
   PubMed Web of Science ®Google Scholar
• Becker BW, Thames AD, Woo E, Castellon SA, Hinkin CH. Longitudinal change in cognitive function and medication adherence in HIV-infected adults. AIDS Behav 2011; Epub ahead of print.
   Google Scholar
• El-Khatib Z, Ekstrom AM, Coovadia A, Abrams EJ, Petzold M, Katzenstein D, Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa – a prospective cohort study. BMC Public Health 2011;11:88.
   PubMedGoogle Scholar
• Ha NB, Ha NB, Garcia RT, Trinh HN, Chaung KT, Nguyen HA, Medication nonadherence with long-term management of patients with hepatitis B e antigen-negative chronic hepatitis B. Dig Dis Sci 2011; [Epub ahead of print].
   Google Scholar